Home
Conditions
Immunoglobulin Light-chain Amyloidosis

Clinical trial condition

Immunoglobulin Light-chain Amyloidosis

Explore clinical trials studying Immunoglobulin Light-chain Amyloidosis. Study availability and eligibility vary by location and protocol.

187 public trials 43 recruiting studies

Refine in advanced search Browse all conditions

Immunoglobulin Light-chain Amyloidosis trial results

Completed

Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction

NCT00547365

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States

St. Mary's Medical Center Powell, Tennessee, United States

View Trial Details

Completed

Radioimmunoimaging of Light Chain (AL) Amyloidosis

NCT01815086

Conditions: AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations: University of Tennessee Medical Center Knoxville, Tennessee, United States

View Trial Details

Completed

Radioimmunoimaging of AL Amyloidosis

NCT00807872

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations: University of Tennessee Medical Center Knoxville, Tennessee, United States

View Trial Details

Completed

Pyroxamide in Treating Patients With Advanced Cancer

NCT00042900

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +90 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

NCT00564889

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00060255

Conditions: Amyloidosis, Blast Crisis, Blood Protein Disorders, +84 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

NCT00003406

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Midwestern Regional Medical Center Zion, Illinois, United States

View Trial Details

Completed

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

NCT00823524

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: University of Ulsan, Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

NCT00002980

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Beckman Research Institute, City of Hope Duarte, California, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

Los Angeles County-University of Southern California Medical Center Los Angeles, California, United States

University of California Davis Cancer Center Sacramento, California, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

NCT00025415

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Immunoglobulin Light-chain Amyloidosis

Immunoglobulin Light-chain Amyloidosis trial results

Related conditions